|
From “undruggable” to impact: Allan Jordan on PARG inhibitors, research tools, and giving patients more tomorrows
|
10th August 2026
|
Read
|
|
The resistant MCF-7 and T47D cell lines I built myself – and why it was worth it
|
6th July 2026
|
Read
|
|
Rethinking drug discovery in glioblastoma
|
22nd June 2026
|
Read
|
|
Using Plasmax™ to uncover steroid-induced metabolic vulnerabilities in glioblastoma
|
11th June 2026
|
Read
|
|
Focus on: Colorectal cancer research tools
|
1st June 2026
|
Read
|
|
Cutting edge tools for lung cancer research and drug discovery
|
29th May 2026
|
Read
|
|
Model glioma heterogeneity, progression and treatment response with confidence
|
27th May 2026
|
Read
|
|
GCGR glioma stem cell panel
|
26th May 2026
|
Read
|
|
Focus on: Comprehensive models for ovarian cancer research and drug discovery
|
22nd May 2026
|
Read
|
|
Focus on: Leading bladder cancer research tools
|
16th May 2026
|
Read
|
|
Innovative tools for breast cancer research and drug discovery
|
4th May 2026
|
Read
|
|
Bridge the gap between in vivo and in vitro cancer cell metabolism
|
27th April 2026
|
Read
|
|
Focus on: Head and Neck cancer research tools
|
27th April 2026
|
Read
|
|
Bridging the translational gap with TRACERx Lung Cancer PDX models
|
20th April 2026
|
Read
|
|
Where innovation deserves protection – and gives back to research
|
13th April 2026
|
Read
|
|
Understanding the impact of EGFR signalling in NSCLC
|
27th March 2026
|
Read
|
|
Brainbow antibodies: from Dawen Cai’s lab to researchers worldwide
|
16th March 2026
|
Read
|
|
How are researchers using the KPC cell line to answer the toughest questions in pancreatic cancer?
|
23rd February 2026
|
Read
|
|
Dissecting the Bladder Tumour Microenvironment with MB49
|
21st January 2026
|
Read
|
|
Build once, use widely, discover faster
|
14th January 2026
|
Read
|
|
Driving discovery with our cancer cell lines
|
10th December 2025
|
Read
|
|
Advancing pancreatic cancer research with the KPC cell line
|
24th November 2025
|
Read
|
|
Focus on: UM-UC panel
|
30th September 2025
|
Read
|
|
The HGS cell line series
|
22nd August 2025
|
Read
|
|
Modelling treatment resistance in ovarian cancer: exploring the PEO series
|
25th June 2025
|
Read
|
